What Is a FibroScan?

FibroScan®, also known as transient elastography, is a noninvasive diagnostic test used to assess the health of the liver. It measures liver stiffness (which correlates with fibrosis or scarring) and fat content in the liver (steatosis). Unlike a liver biopsy, FibroScan does not require needles, incisions, or sedation, and it can be completed in just a few minutes in an outpatient setting.

FibroScan is commonly used to evaluate and monitor chronic liver diseases such as fatty liver disease, viral hepatitis, alcohol-related liver disease, and cirrhosis.

Diagnostic Features / Indications

FibroScan is used to:

• Assess the degree of liver fibrosis (scarring)
• Detect and quantify fatty liver (hepatic steatosis)
• Monitor progression or improvement of liver disease over time
• Reduce the need for liver biopsy in many patients
  
  

Common conditions where FibroScan is helpful include:

• Metabolic Dysfunction-Associated Steatotic Liver Disease (MAFLD) / MASLD
• Alcohol-related liver disease
• Chronic hepatitis B or C
• Autoimmune liver disease
• Suspected or known cirrhosis
• Abnormal liver enzymes of unclear cause

Surveillance and Disease Monitoring

FibroScan is frequently used for long-term monitoring, including:

• Tracking fibrosis progression or regression
• Monitoring response to lifestyle changes or medical therapy
• Risk stratification for complications of chronic liver disease
• Ongoing surveillance in patients with known liver fibrosis
  
  

Because it is safe and repeatable, FibroScan is ideal for serial follow-up testing.

Advantages of FibroScan

• Noninvasive and painless
• No sedation or anesthesia required
• Quick (typically 5–10 minutes)
• Performed in the office or outpatient clinic
• Immediate results
• No recovery time
• Lower risk compared to liver biopsy

Limitations

While FibroScan is highly useful, it does have limitations:

• Results may be less accurate in patients with:

  • Severe obesity
  • Significant fluid in the abdomen (ascites)
  • Acute liver inflammation
    
    
• It does not replace biopsy when detailed tissue analysis is required
• Measures stiffness, not the underlying cause of liver disease
  
  

Your gastroenterologist will interpret FibroScan results in combination with labs, imaging, and clinical findings.

Complications and Safety

FibroScan is considered extremely safe.

• No radiation exposure
• No risk of bleeding or infection
• No known serious complications
  
  

Patients may feel a brief vibration or tapping sensation over the right upper abdomen during the test, but it is not painful.

Procedure

• The patient lies on their back with the right arm raised behind the head.
• A water-based gel is applied to the skin over the liver area.
• A small probe is placed between the ribs on the right side.
• The probe sends painless vibrations into the liver and measures how fast they travel.
• Multiple readings are taken to ensure accuracy.

The test usually takes 5–10 minutes, and patients may resume normal activities immediately afterward.

Preparation

• Patients are typically asked to fast for at least 3–4 hours before the test.
• No medications need to be stopped unless directed by the physician.

Results

FibroScan provides two main results:

• Liver stiffness measurement (kPa) – reflects fibrosis or scarring
• CAP score (Controlled Attenuation Parameter) – reflects liver fat content
  
  

Results are reviewed by a gastroenterologist or hepatologist, who will explain their clinical significance and next steps.

Summary

FibroScan is a fast, safe, and reliable tool for evaluating liver health. It has become an essential part of modern gastroenterology and hepatology care, allowing physicians to diagnose, monitor, and manage liver disease without invasive procedures.

If you have abnormal liver tests or known liver disease, FibroScan may be an important part of your evaluation.